Matthew Mei

机构：City Of Hope National Medical Center, City of Hope · ORCID：0000-0002-1109-6955

发表论文 278 篇 · 总被引 4203 次 · h-index 34

代表论文

• PD-1–based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphoma (2025 · Blood · 被引 4)
• A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis (2025 · Blood Advances · 被引 4)
• Real-world infectious complications of CD3/CD20 bispecific antibodies in relapsed/refractory non-Hodgkin lymphoma (2025 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 4)
• Precise-HL trial: Personalized reduction of chemotherapy intensity through ctdna evaluation in advanced Hodgkin lymphoma (2025 · Blood · 被引 3)
• Selection of a Salvage Regimen for Relapsed or Refractory Classic Hodgkin Lymphoma in the Era of Novel Therapies (2026 · Hematology/Oncology Clinics of North America · 被引 2)
• Autologous CD30.CAR-T-cell therapy in patients with relapsed or refractory classical Hodgkin lymphoma – long term update of the chariot trial (2025 · Blood · 被引 2)